HMGB1 and COVID-19: Interestingly, an upregulation of the receptor for advanced glycation end products (RAGE) and HMGB1 is also found among patients with the most severe forms of COVID-19 [125], which indicates the harmful effects of augmented HMGB1 in respiratory viral infections.